HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark A Hull Selected Research

Adenoma (Adenomas)

1/2022Omega-3 polyunsaturated fatty acids: moving towards precision use for prevention and treatment of colorectal cancer.
4/2021Reduction in the resident intestinal myelomonocytic cell population occurs during ApcMin/+ mouse intestinal tumorigenesis.
1/2021Nutritional prevention of colorectal cancer.
12/2018Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.
1/2017Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc Min/+ mouse model of intestinal tumorigenesis.
7/2013A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
2/2012Aspirin in the chemoprevention of colorectal neoplasia: an overview.
8/2010Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells.
11/2005Macrophage migration inhibitory factor promotes intestinal tumorigenesis.
7/2004Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark A Hull Research Topics

Disease

36Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 01/2002
25Neoplasms (Cancer)
11/2023 - 10/2002
14Carcinogenesis
01/2022 - 01/2002
13Polyps
11/2023 - 10/2002
13Adenoma (Adenomas)
01/2022 - 10/2002
7Neoplasm Metastasis (Metastasis)
11/2023 - 09/2003
7Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
04/2021 - 11/2005
5Inflammation (Inflammations)
11/2014 - 10/2002
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018 - 01/2015
3Obesity
01/2021 - 06/2008
2Adenomatous Polyps
11/2023 - 01/2013
2Hemorrhage
01/2023 - 12/2018
2Ulcerative Colitis
11/2022 - 01/2015
2Microsatellite Instability
01/2022 - 12/2016
2Breast Neoplasms (Breast Cancer)
01/2020 - 11/2013
2Crohn Disease (Crohn's Disease)
01/2019 - 01/2015
1Cholangitis
11/2022
1Melanoma (Melanoma, Malignant)
04/2021
1Colonic Neoplasms (Colon Cancer)
01/2019
1Ataxia (Dyssynergia)
01/2018
1Colitis-Associated Neoplasms
11/2014
1Carcinoma (Carcinomatosis)
11/2013
1Hypoxia (Hypoxemia)
02/2013
1Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
02/2012
1Vascular Diseases (Vascular Disease)
02/2012
1Cardiovascular Diseases (Cardiovascular Disease)
02/2012
1Morbid Obesity
07/2011
1Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2011

Drug/Important Bio-Agent (IBA)

16Eicosapentaenoic AcidIBA
11/2023 - 07/2010
15Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
11/2023 - 07/2010
10Biomarkers (Surrogate Marker)IBA
10/2023 - 09/2003
8Nonesterified Fatty Acids (NEFA)IBA
11/2023 - 07/2010
8Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2023 - 10/2002
8Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2023 - 01/2012
7Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2023 - 10/2002
6Dinoprostone (PGE2)FDA Link
11/2023 - 08/2004
5ProstaglandinsIBA
02/2013 - 07/2004
4Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2021 - 11/2014
4Proteins (Proteins, Gene)FDA Link
11/2005 - 01/2002
3Calcibiotic Root Canal SealerIBA
11/2022 - 12/2016
3Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2006 - 09/2003
2LipidsIBA
11/2023 - 01/2022
2insulin receptor-related receptor (IRR)IBA
11/2023 - 10/2023
2CateninsIBA
04/2021 - 01/2017
215-hydroxyprostaglandin dehydrogenaseIBA
01/2020 - 02/2013
2ParaffinIBA
12/2016 - 01/2006
2Formaldehyde (Formol)FDA Link
12/2016 - 01/2006
2Macrophage Migration-Inhibitory FactorsIBA
07/2011 - 11/2005
2rofecoxib (Vioxx)FDA Link
01/2006 - 09/2003
2Messenger RNA (mRNA)IBA
11/2005 - 07/2004
1eicosapentaenoic acid ethyl esterIBA
11/2023
1EstersIBA
11/2023
1OxylipinsIBA
11/2023
1Lipoxygenase (Lipoxygenase-1)IBA
11/2023
1Arachidonic Acid (Vitamin F)IBA
01/2022
1enhanced green fluorescent proteinIBA
04/2021
1lysyllysine (Lys-Lys)IBA
04/2021
1mouse lysozyme MIBA
04/2021
1Vitamin DFDA LinkGeneric
01/2021
1CalciumIBA
01/2021
1TamoxifenFDA LinkGeneric
01/2020
1Cetuximab (Erbitux)FDA Link
01/2019
1Opiate AlkaloidsIBA
01/2018
1Fatty Acids (Saturated Fatty Acids)IBA
01/2018
1TP-252IBA
01/2018
1EicosanoidsIBA
01/2018
1Folic Acid (Vitamin M)FDA LinkGeneric
03/2017
1Muramidase (Lysozyme)IBA
01/2017
1GuaiacIBA
12/2016
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
05/2016
1ChemokinesIBA
05/2016
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2016
1Dietary Fats (Dietary Fat)IBA
11/2014
1MicroRNAs (MicroRNA)IBA
11/2013
1CarcinogensIBA
10/2013
1Type II Interleukin-4 ReceptorsIBA
10/2013
1InterleukinsIBA
10/2013
1Warfarin (Coumadin)FDA LinkGeneric
07/2013
1Fish OilsIBA
07/2013
1EnzymesIBA
02/2013
1Hydroxyprostaglandin Dehydrogenases (Hydroxyprostaglandin Dehydrogenase)IBA
02/2013
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2013
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2012
1Insulin (Novolin)FDA Link
04/2011
1LeptinIBA
04/2011
1Insulin-Like PeptidesIBA
04/2011
1AdipokinesIBA
04/2011
1prostaglandin D2 receptorIBA
07/2004
1Antineoplastic Agents (Antineoplastics)IBA
09/2003

Therapy/Procedure

13Chemoprevention
11/2023 - 10/2002
8Therapeutics
04/2021 - 08/2004
4Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2021 - 06/2008
3Bariatric Surgery
11/2018 - 06/2008
2Colectomy
11/2022 - 01/2018
1Precision Medicine
12/2018
1Oral Administration
11/2014
1Gastrectomy
01/2014
1Tattooing
07/2010
1Investigational Therapies (Experimental Therapy)
01/2006
1Drug Therapy (Chemotherapy)
09/2003